Correction: Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials.

ABSTRACT:

SUBMITTER: Jabbour E 

PROVIDER: S-EPMC11436350 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature